EORTC (@eortc) 's Twitter Profile
EORTC

@eortc

European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life

ID: 414752636

linkhttp://www.eortc.org calendar_today17-11-2011 12:56:47

3,3K Tweet

15,15K Followers

705 Following

EORTC (@eortc) 's Twitter Profile Photo

✨Last month, Dr Denis Lacombe, EORTC CEO, shared insights about the Cancer Medicines Forum during a live webinar hosted by Cancer Drug Development Forum (CDDF). You can take a look at the key takeaways below. 👇 #CancerMedicinesForum #CancerResearch #ClinicalTrials #Oncology

EORTC (@eortc) 's Twitter Profile Photo

📢Join the EORTC HQ team in #Brussels for one-year and become our next #QualityOfLife research fellow. This position is focused on patient-reported outcomes in #cancer #ClinicalTrials. Apply now: eortc.org/job/fellowship… #CancerResearch #Oncology #Fellowship #WorkWithUs #Vacancy

📢Join the EORTC HQ team in #Brussels for one-year and become our next #QualityOfLife research fellow. This position is focused on patient-reported outcomes in #cancer #ClinicalTrials.

Apply now: eortc.org/job/fellowship…

#CancerResearch #Oncology #Fellowship #WorkWithUs #Vacancy
EORTC (@eortc) 's Twitter Profile Photo

📢 Are you a recently specialised radiation or medical oncologist passionate about clinical #CancerResearch and #Radiotherapy? 🚀 Apply now: eortc.org/job/fellowship… #WorkWithUs #Vacancy #Jobs #Radiotherapy #RTQA

📢 Are you a recently specialised radiation or medical oncologist passionate about clinical #CancerResearch and #Radiotherapy? 

🚀 Apply now: eortc.org/job/fellowship…

#WorkWithUs #Vacancy #Jobs #Radiotherapy #RTQA
EORTC (@eortc) 's Twitter Profile Photo

📚 Proud to share a new EORTC #publication on RP-2321-GITCG ASPIRE, the first global study evaluating the interchangeability of programmed death-ligand 1 (PD-L1) scoring systems and assays in #gastroesophagealcancer. 👉doi.org/10.1016/j.esmo… #CancerResearch #ClinicalTrials

📚 Proud to share a new EORTC #publication on RP-2321-GITCG ASPIRE, the first global study evaluating the interchangeability of programmed death-ligand 1  (PD-L1) scoring systems and assays in #gastroesophagealcancer.

👉doi.org/10.1016/j.esmo…

#CancerResearch #ClinicalTrials
EORTC (@eortc) 's Twitter Profile Photo

🎙️Roger Wilson is a #sarcoma patient and the founder of Sarcoma UK one of EORTC’s funding partners of the EORTC-lead STRASS/STREXIT 2 Project trial on #RetroperitonealSarcoma. Learn more about his story: thewaitingroom.karger.com/interviews/sar…

EORTC (@eortc) 's Twitter Profile Photo

📚 New publication available about the #E2RADIatE #OligoCare cohort, the largest prospective registry cohort on oligometastatic disease. This interim analysis confirmed that stereotactic body radiotherapy is safe to use in the oligometastatic setting. 👉doi.org/10.1016/j.rado…

📚 New publication available about the #E2RADIatE #OligoCare cohort, the largest prospective registry cohort on oligometastatic disease.

This interim analysis confirmed that stereotactic body radiotherapy is safe to use in the oligometastatic setting.

👉doi.org/10.1016/j.rado…
EORTC (@eortc) 's Twitter Profile Photo

🚀 Final opportunity for exhibition at #ENASymp24! Only 2 exhibition spaces left at ENA in Barcelona. Highlight your cutting-edge drug developments and connect with key leaders in oncology. Secure your spot today! Download the prospectus: event.eortc.org/ena2024/indust… AACR National Cancer Institute

🚀 Final opportunity for exhibition at #ENASymp24!

Only 2 exhibition spaces left at ENA in Barcelona. Highlight your cutting-edge drug developments and connect with key leaders in oncology. Secure your spot today!

Download the prospectus: event.eortc.org/ena2024/indust…

<a href="/AACR/">AACR</a> <a href="/theNCI/">National Cancer Institute</a>
EORTC (@eortc) 's Twitter Profile Photo

📢 Have you read our latest publication in The Lancet Oncology? This study highlights the importance of assessing long-term health-related #qualityoflife in #melanoma patients following adjuvant PD-1 inhibitor treatment. 👉 Find out more: doi.org/10.1016/S1470-…

📢 Have you read our latest publication in <a href="/TheLancetOncol/">The Lancet Oncology</a>?

This study highlights the importance of assessing long-term health-related #qualityoflife in #melanoma patients following adjuvant PD-1 inhibitor treatment.

👉 Find out more: doi.org/10.1016/S1470-…
EORTC (@eortc) 's Twitter Profile Photo

📢 Don't miss out on our upcoming Multi-Stakeholder Workshop on "Innovation and Access in #RareCancers" with Cancer Drug Development Forum (CDDF). This hybrid event takes place on 23-24 September 2024. 👉Register now: cddf.org/events/upcomin… #CancerResearch #ClinicalTrials #Oncology

EORTC (@eortc) 's Twitter Profile Photo

Prepare your Late Breaking Abstracts for #ENASymp24! Showcase breakthroughs in drug development, translational research & more. ❗Submission: 18-25 September event.eortc.org/ena2024/late-b… AACR National Cancer Institute Elisabeth de Vries Tim Greten soria Paolo Tarantino Elena Garralda Eytan Ruppin, MD, PhD

EORTC (@eortc) 's Twitter Profile Photo

⏰ Only a few days left to secure your spot to attend in person the CDDF & EORTC Multi-Stakeholder Workshop on “Innovation and Access in #RareCancers”! Onsite registration closes on 1 September 2024. Don't miss out! 👉 eortc.org/event/innovati… #CancerResearch #ClinicalTrials

EORTC (@eortc) 's Twitter Profile Photo

🚀 Don't miss the session on AI in drug development and clinical trials at #ENASymp24 on 24 Oct, 5:00-6:30 PM chaired by Rudolf Fehrmann and Caroline Chung, MD ⏳ Regular rate registrations end on 4 Sep. View the programme: cm.eortc.org/cmPortal/Searc…

🚀 Don't miss the session on AI in drug development and clinical trials at #ENASymp24 on 24 Oct, 5:00-6:30 PM chaired by <a href="/rsnfehrmann/">Rudolf Fehrmann</a> and <a href="/ca_chung/">Caroline Chung, MD</a>

⏳ Regular rate registrations end on 4 Sep.

View the programme: cm.eortc.org/cmPortal/Searc…
EORTC (@eortc) 's Twitter Profile Photo

Don’t miss the #BIGEORTC24 webinar, celebrating 25 years of #BreastCancer research! 📅 Join us on 16 Oct 2024, 1-2 PM CEST. Details coming soon! #HealthUnion #EUHPP BIG against Breast Cancer

Don’t miss the #BIGEORTC24 webinar, celebrating 25 years of #BreastCancer research!

📅 Join us on 16 Oct 2024, 1-2 PM CEST.

Details coming soon!

#HealthUnion #EUHPP <a href="/BIGagainstBC/">BIG against Breast Cancer</a>
EORTC (@eortc) 's Twitter Profile Photo

📢 The EORTC Clinical Operations Department is seeking two Junior Clinical Operations Managers to strengthen its team at our HQ in #Brussels. Apply now: eortc.org/job/junior-cli… #ClinicalOperationsManager #Healthcare #Vacancy #WorkWithUs #Jobs #CancerResearch

📢 The EORTC Clinical Operations Department is seeking two Junior Clinical Operations Managers to strengthen its team at our HQ in #Brussels.

Apply now: eortc.org/job/junior-cli… 

#ClinicalOperationsManager #Healthcare #Vacancy #WorkWithUs #Jobs #CancerResearch
EORTC (@eortc) 's Twitter Profile Photo

⏰ Final opportunity to benefit from the regular rate at #ENASymp24. Closes today at 23:59 CEST. Join us in Barcelona, 23-25 Oct 2024. Register now: event.eortc.org/ena2024/regist… AACR, National Cancer Institute, Elisabeth de Vries, Tim Greten, soria, Paolo Tarantino, Elena Garralda, Eytan Ruppin, MD, PhD

⏰ Final opportunity to benefit from the regular rate at #ENASymp24. Closes today at 23:59 CEST. 

Join us in Barcelona, 23-25 Oct 2024. 

Register now: event.eortc.org/ena2024/regist…

<a href="/AACR/">AACR</a>, <a href="/theNCI/">National Cancer Institute</a>, <a href="/VriesElisabeth/">Elisabeth de Vries</a>, <a href="/TimGreten/">Tim Greten</a>, <a href="/jsoriamd/">soria</a>, <a href="/PTarantinoMD/">Paolo Tarantino</a>, <a href="/ElenaGarralda/">Elena Garralda</a>, <a href="/NCIEytanRuppin/">Eytan Ruppin, MD, PhD</a>
EORTC (@eortc) 's Twitter Profile Photo

📢 Save the Dates: New Y-ECI CLTG and ROSC Webinar Series! Excited to announce a series of webinars dedicated to the latest recommendations in cutaneous lymphomas, focusing on keeping radiation doses ‘as low as reasonably achievable’. More info eortc.org/event/y-eci-cl… #RADCUTIS

📢 Save the Dates:  New Y-ECI CLTG and ROSC Webinar Series!
Excited to announce a series of webinars dedicated to the latest recommendations in cutaneous lymphomas, focusing on keeping radiation doses ‘as low as reasonably achievable’. More info eortc.org/event/y-eci-cl… #RADCUTIS